MedPath
NMPA Approval

Eribulin Mesilate Injection

国药准字H20253131

January 14, 2025

Drug Information

甲磺酸艾立布林注射液

注射剂

2ml:1mg

化学药品

January 14, 2025

Company Information

Applicant Company

江西省赣州市章贡区沙河工业园

Manufacturing Company

成都高新综合保税区科新路8号附9号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

甲磺酸艾立布林注射液 - NMPA 批准文号 | MedPath